Marlies Blom

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. doi request reprint Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice
    M Blom
    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Arthritis Care Res (Hoboken) 62:1335-41. 2010
  2. doi request reprint Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis
    M Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Scand J Rheumatol 42:281-8. 2013
  3. ncbi request reprint Management of established rheumatoid arthritis with an emphasis on pharmacotherapy
    M Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    Best Pract Res Clin Rheumatol 21:43-57. 2007
  4. doi request reprint The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis
    Marlies Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, H 470, 6500 HB Nijmegen, The Netherlands
    J Rheumatol 36:2171-7. 2009
  5. doi request reprint Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis
    Marlies Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands
    J Rheumatol 38:2355-61. 2011
  6. ncbi request reprint Surgical treatment for the vulvar vestibulitis syndrome
    Maaike A F Traas
    Department of Obstetrics and Gynecology, Rijnstate Hospital, Arnhem, The Netherlands
    Obstet Gynecol 107:256-62. 2006
  7. doi request reprint Rituximab treatment in patients with refractory inflammatory myopathies
    Elien A M Mahler
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands
    Rheumatology (Oxford) 50:2206-13. 2011

Detail Information

Publications7

  1. doi request reprint Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice
    M Blom
    Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Arthritis Care Res (Hoboken) 62:1335-41. 2010
    ..To describe the frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in the treatment of rheumatoid arthritis (RA) in daily clinical practice...
  2. doi request reprint Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis
    M Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Scand J Rheumatol 42:281-8. 2013
    ..To investigate the prevalence of cervical spine damage due to rheumatoid arthritis (RA) in the long term and to investigate which disease-specific factors are related to this damage...
  3. ncbi request reprint Management of established rheumatoid arthritis with an emphasis on pharmacotherapy
    M Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    Best Pract Res Clin Rheumatol 21:43-57. 2007
    ....
  4. doi request reprint The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis
    Marlies Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, H 470, 6500 HB Nijmegen, The Netherlands
    J Rheumatol 36:2171-7. 2009
    ..To investigate whether the reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent influences the effect of a second TNF blocking agent...
  5. doi request reprint Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis
    Marlies Blom
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands
    J Rheumatol 38:2355-61. 2011
    ..To compare the effectiveness of a third tumor necrosis factor-α (TNF-α)-blocking agent with rituximab after failure of 2 TNF-blocking agents in patients with rheumatoid arthritis (RA) in daily clinical practice...
  6. ncbi request reprint Surgical treatment for the vulvar vestibulitis syndrome
    Maaike A F Traas
    Department of Obstetrics and Gynecology, Rijnstate Hospital, Arnhem, The Netherlands
    Obstet Gynecol 107:256-62. 2006
    ..To study the outcome and complications of surgical treatment for vulvar vestibulitis syndrome and to identify patient characteristics that may have influenced the outcome...
  7. doi request reprint Rituximab treatment in patients with refractory inflammatory myopathies
    Elien A M Mahler
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands
    Rheumatology (Oxford) 50:2206-13. 2011
    ..1 months of follow-up...